Fri. 23 Aug 2024, 3:29pm ET
Benzinga
Biotech, News, General
McKesson Corp. is in advanced talks to buy a controlling stake in Florida Cancer Specialists & Research Institute, a privately-held operator of oncology clinics, according to people familiar with the matter.
Drug distributor McKesson could pay about $3.5 billion for the holding and a deal may be announced in the coming weeks, the people said, asking not to be named because the matter is private. McKesson has been competing with other bidders for the asset, they said.